![Dan Spiegelman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dan Spiegelman
Directeur/Membre du Conseil chez
VTV THERAPEUTICS INC.
Fortune : 269 552 $ au 31/05/2026
Profil
Daniel K.
Spiegelman was the founder of Rapidscan Pharma Solutions, Inc., founded in 2010, where the title held was Chief Financial Officer from 2010 to 2012.
Current jobs include Chairman at Tizona Therapeutics, Inc. since 2019; Independent Director at Spruce Biosciences, Inc. since 2020; Independent Director at Maze Therapeutics, Inc. since 2020; Director at Bluejay Therapeutics, Inc. since 2024; Independent Director at Jiya Acquisition Corp.
since 2020; Independent Director at vTv Therapeutics, Inc. since 2024; Venture Partner at Samsara BioCapital LLC since 2023; and President at Recardia Therapeutics, Inc. since 2020.
Former jobs include Chief Executive Officer at Filtini, Inc. from 2009 to 2012; Chairman at Relypsa, Inc. from 2014 to 2016; Director at Xcyte Therapies, Inc. in 2006; Director at Omeros Corp.
from 2009 to 2012; Independent Director at Anthera Pharmaceuticals, Inc. from 2011 to 2014; Director at SillaJen Biotherapeutics, Inc.; Independent Director at Cascadian Therapeutics LLC from 2011 to 2018; Independent Director at Affymax, Inc. from 2011 to 2013; Independent Director at Bio Green Med Solution, Inc.; Independent Director at Kyverna Therapeutics, Inc. from 2021 to 2026; Independent Director at Myriad Genetics, Inc. from 2020 to 2024; Independent Non-Executive Director at Opthea Ltd. from 2020 to 2024; Treasurer at Genentech, Inc. from 1991 to 1998; Chief Financial Officer & Senior Vice President at CV Therapeutics, Inc. from 1998 to 2009; Chief Financial Officer & Executive Vice President at BioMarin Pharmaceutical, Inc. from 2012 to 2020.
Education includes an undergraduate degree from Stanford University conferred in 1980 and an MBA from Stanford Graduate School of Business conferred in 1983.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 29/05/2025 | 16 634 ( 0,03 % ) | 141 722 $ | 31/05/2026 | |
| 01/04/2026 | 3 833 ( 0,1 % ) | 127 831 $ | 31/05/2026 | |
| 21/05/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
Maze Therapeutics, Inc.
 Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases -.--% | 08/06/2026 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Dan Spiegelman
| Sociétés | Poste | Début |
|---|---|---|
| SPRUCE BIOSCIENCES, INC. | Directeur/Membre du Conseil | 09/09/2020 |
| JIYA ACQUISITION CORP. | Directeur/Membre du Conseil | 18/11/2020 |
| VTV THERAPEUTICS INC. | Directeur/Membre du Conseil | 11/06/2024 |
Samsara Biocapital LLC
 Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Private Equity Investor | 01/04/2023 |
Recardia Therapeutics, Inc. | President | 01/07/2020 |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Directeur/Membre du Conseil | 01/10/2020 |
Tizona Therapeutics, Inc.
 Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Président | 15/05/2019 |
Bluejay Therapeutics, Inc.
 Bluejay Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics treatments for viral and liver diseases | Directeur/Membre du Conseil | 10/10/2024 |
Anciens postes connus de Dan Spiegelman
| Sociétés | Poste | Fin |
|---|---|---|
| KYVERNA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 24/02/2026 |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░ ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░░░░ ░░░ ░░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Dan Spiegelman
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
79
Relations au 1er degré
26
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 26 |
|---|---|
Genentech, Inc.
 Genentech, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that develops medicines for cancer peoples | Health Technology |
CV Therapeutics, Inc.
 CV Therapeutics, Inc. BiotechnologyHealth Technology Develops small molecule drugs | Health Technology |
Myriad Genetics, Inc.
 Myriad Genetics, Inc. Medical SpecialtiesHealth Technology Develops therapeutic and predictive medicine products | Health Technology |
BioMarin Pharmaceutical, Inc.
 BioMarin Pharmaceutical, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes innovative pharmaceuticals for serious diseases & medical conditions | Health Technology |
Xcyte Therapies, Inc.
 Xcyte Therapies, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic products | Health Technology |
Omeros Corp.
 Omeros Corp. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes small-molecule & protein therapeutics | Health Technology |
Anthera Pharmaceuticals, Inc.
 Anthera Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in development and commercialization of medicines for patients with unmet medical needs | Health Technology |
SillaJen Biotherapeutics, Inc.
 SillaJen Biotherapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a biotechnology company provides clinical research and development services | Commercial Services |
Cascadian Therapeutics LLC
 Cascadian Therapeutics LLC Medical SpecialtiesHealth Technology Develops therapeutic products for the treatment of cancer | Health Technology |
Stanford University
 Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Opthea Ltd.
 Opthea Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops novel therapies for treatment retinal diseases | Health Technology |
Affymax, Inc.
 Affymax, Inc. BiotechnologyHealth Technology Develops and distributes pharmaceutical products | Health Technology |
Cyclacel Pharmaceuticals, Inc.
 Cyclacel Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Discovers, develops and commercializes mechanism-targeted drugs to treat human cancers | Health Technology |
Relypsa, Inc.
 Relypsa, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops non-absorbed polymeric drugs for applications in cardiovascular and renal diseases | Health Technology |
Rapidscan Pharma Solutions, Inc.
 Rapidscan Pharma Solutions, Inc. Medical/Nursing ServicesHealth Services Provides novel technologies for the diagnosis of disease | Health Services |
Filtini, Inc. | |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
vTv Therapeutics, Inc.
 vTv Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company which engages in discovery and development of orally administered small molecule drugs for treating metabolic and inflammatory disorders | Health Technology |
Tizona Therapeutics, Inc.
Tizona Therapeutics, Inc. BiotechnologyHealth Technology Develops and manufactures immuno therapies | Health Technology |
Samsara Biocapital LLC
Samsara Biocapital LLC Investment ManagersFinance Samsara BioCapital invests in companies located in the United States. The firm targets companies operating in the fields of biotechnology and pharmaceuticals. It provides early and later stage capital requirements. | Finance |
Spruce Biosciences, Inc.
 Spruce Biosciences, Inc. BiotechnologyHealth Technology Operates as biopharmaceutical company which develops novel therapies for endocrine diseases | Health Technology |
Maze Therapeutics, Inc.
Maze Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops medicine for cardiovascular, renal and metabolic diseases | Health Technology |
Kyverna Therapeutics, Inc.
 Kyverna Therapeutics, Inc. BiotechnologyHealth Technology Operates as a cell therapy company which develops treatments and potential cures for serious autoimmune diseases | Health Technology |
Jiya Acquisition Corp.
 Jiya Acquisition Corp. Financial ConglomeratesFinance Operates as a blank check company | Finance |
Bluejay Therapeutics, Inc.
Bluejay Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics treatments for viral and liver diseases | Health Technology |
Recardia Therapeutics, Inc. |
